Comparison of Male and Female Sexual Dysfunction between Hemodialysis and Peritoneal Dialysis in Patients with End-Stage Renal Disease: An Analytical Cross-Sectional Study.


Journal

International journal of endocrinology
ISSN: 1687-8337
Titre abrégé: Int J Endocrinol
Pays: Egypt
ID NLM: 101516376

Informations de publication

Date de publication:
2022
Historique:
received: 10 10 2021
accepted: 10 03 2022
entrez: 28 4 2022
pubmed: 29 4 2022
medline: 29 4 2022
Statut: epublish

Résumé

Maintenance dialysis is the most common treatment for end-stage renal disease (ESRD) patients. One of the most ignored but important health issue among dialysis patients is sexual dysfunction, which interferes with quality of life (QoL). Studies showed that the side effects of the two conventional methods of dialysis (hemodialysis (HD) and peritoneal dialysis (PD)) are different on a patient's health. Therefore, we sought to compare the sexual dysfunction score, both male and female, between patients undergoing HD and PD. One hundred seventy adults (85 HD and 85 PD) subject with end-stage renal disease (ESRD) on dialysis for at least 2 months were included. For male subjects, the erectile function (EF) domain of the International Index of Erectile Function (IIEF) questionnaire was calculated. Moreover, the Female Sexual Function Index (FSFI) questionnaire was calculated for females. Data were analyzed via SPSS software. Two independent sample Out of 170 patients with mean age of 49.34 ± 11.7 years, 52.9% were female. Better sexual function scores were obtained in the HD group's females for desire, orgasm, and satisfaction domains, as well as the total score ( We found better sexual life in the HD group's females and PD group's males. Considering dialysis as a life-long treatment of CKD patients, this part of a patient's life must be taken seriously by the healthcare providers to choose the most suitable method for patients based on their personalized conditions.

Sections du résumé

Background UNASSIGNED
Maintenance dialysis is the most common treatment for end-stage renal disease (ESRD) patients. One of the most ignored but important health issue among dialysis patients is sexual dysfunction, which interferes with quality of life (QoL). Studies showed that the side effects of the two conventional methods of dialysis (hemodialysis (HD) and peritoneal dialysis (PD)) are different on a patient's health. Therefore, we sought to compare the sexual dysfunction score, both male and female, between patients undergoing HD and PD.
Methods UNASSIGNED
One hundred seventy adults (85 HD and 85 PD) subject with end-stage renal disease (ESRD) on dialysis for at least 2 months were included. For male subjects, the erectile function (EF) domain of the International Index of Erectile Function (IIEF) questionnaire was calculated. Moreover, the Female Sexual Function Index (FSFI) questionnaire was calculated for females. Data were analyzed via SPSS software. Two independent sample
Results UNASSIGNED
Out of 170 patients with mean age of 49.34 ± 11.7 years, 52.9% were female. Better sexual function scores were obtained in the HD group's females for desire, orgasm, and satisfaction domains, as well as the total score (
Conclusion UNASSIGNED
We found better sexual life in the HD group's females and PD group's males. Considering dialysis as a life-long treatment of CKD patients, this part of a patient's life must be taken seriously by the healthcare providers to choose the most suitable method for patients based on their personalized conditions.

Identifiants

pubmed: 35479663
doi: 10.1155/2022/9404025
pmc: PMC9038412
doi:

Types de publication

Journal Article

Langues

eng

Pagination

9404025

Informations de copyright

Copyright © 2022 Shahryar Zeighami et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest.

Références

Arch Gerontol Geriatr. 2012 Jan-Feb;54(1):140-5
pubmed: 21555158
Nefrologia. 2014 Nov 17;34(6):703-9
pubmed: 25335087
Int Urol Nephrol. 2009;41(3):473-81
pubmed: 18853272
Kidney Int. 1981 Feb;19(2):341-8
pubmed: 7230619
Ther Apher Dial. 2014 Oct;18(5):375-82
pubmed: 24571450
Ren Fail. 2009;31(5):360-4
pubmed: 19839835
Curr Opin Nephrol Hypertens. 2018 Nov;27(6):463-471
pubmed: 30148722
BMC Health Serv Res. 2015 Nov 12;15:506
pubmed: 26563300
PLoS One. 2016 Jul 06;11(7):e0158765
pubmed: 27383068
Int J Impot Res. 2002 Dec;14(6):539-42
pubmed: 12494292
J Sex Marital Ther. 2000 Apr-Jun;26(2):191-208
pubmed: 10782451
Sichuan Da Xue Xue Bao Yi Xue Ban. 2005 Jul;36(4):555-8
pubmed: 16078587
Semin Dial. 2016 Jan-Feb;29(1):19-23
pubmed: 26138753
Ren Fail. 2006;28(6):451-6
pubmed: 16928612
Kidney Int. 2019 Jul;96(1):37-47
pubmed: 30987837
Kidney Int. 2001 Jun;59(6):2259-66
pubmed: 11380829
PLoS One. 2017 Jun 20;12(6):e0179511
pubmed: 28632793
Kidney Int. 1999 Sep;56(3):1129-35
pubmed: 10469383
Cardiol Res Pract. 2021 Mar 13;2021:6647995
pubmed: 33815837
Kidney Int. 2003 Jul;64(1):232-8
pubmed: 12787414
J Sex Med. 2009 Apr;6(4):1062-1071
pubmed: 19175866
Indian J Endocrinol Metab. 2012 Mar;16(2):214-9
pubmed: 22470857
J Urol. 2000 Mar;163(3):888-93
pubmed: 10688001
Semin Dial. 2013 May-Jun;26(3):278-80
pubmed: 23458106
J Am Soc Nephrol. 2004 Mar;15(3):743-53
pubmed: 14978177
Saudi J Kidney Dis Transpl. 2011 Mar;22(2):232-6
pubmed: 21422619
Saudi J Kidney Dis Transpl. 2007 Jun;18(2):191-4
pubmed: 17496393
Ann Transplant. 2014 Nov 09;19:576-85
pubmed: 25382249
Nephrol Dial Transplant. 2001 Sep;16(9):1818-22
pubmed: 11522864
Nephrol Dial Transplant. 1997 Dec;12(12):2654-63
pubmed: 9430867

Auteurs

Shahryar Zeighami (S)

Department of Urology, Shiraz University of Medical Sciences, Shiraz, Iran.

Saeid Dehghankhalili (S)

Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.

Khadije Heiran (K)

Department of Midwifery, School of Nursing and Midwifery, Zahedan University of Medical Sciences, Zahedan, Iran.

Seyede Pegah Azarchehry (SP)

Department of Biochemistry, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.

Alireza Heiran (A)

Non-Communicable Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Mehrab Sayadi (M)

Cardiovascular Research Center, Mohammad Rasoolallah Research Tower, Shiraz University of Medical Sciences, Shiraz, Iran.

Fatemeh Azadian (F)

Non-Communicable Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Classifications MeSH